Smith & Nephew rebuffs bid from J & J

Share this article:

Wound care firm Smith & Nephew rejected a $10.9 billion acquisition offer from Johnson & Johnson.

Smith & Nephew CEO David Illingworth declined to comment on the bid, sending his firm's stock prices soaring by more than 10%. “Speculation has been going on for 10 years,” he said at a J.P. Morgan Healthcare Conference in San Francisco.

J&J spokesman Jeff Leebaw also declined comment.

Sky News reported that Johnson & Johnson approached its rival in December with the  11-figure proposal. But the outlet did not cite sources, or indicate where it had received its information.

Johnson & Johnson was considering whether or not to come back with a raised offer, according to several other published reports.

The allegation that Smith & Nephew received and rejected a bid without informing shareholders reopened debate on when companies should be required to make bids known to the market.

It is generally accepted that companies should not have to reveal all bids received. Some argue that there must be something wrong with the system if boards can withhold information about serious bids.
Share this article:

More in News

ACO bill in House would waive 3-midnight requirement for skilled nursing care

Certain Accountable Care Organizations would be able to send Medicare beneficiaries to a skilled nursing facility without a prior hospital stay under a bipartisan bill recently introduced in the House of Representatives.

Increasing staff-to-patient ratios improves nurse safety, researchers find

A law setting mandatory nurse-to-patient staffing ratios has reduced the number of workplace injuries for registered nurses and licensed practical nurses in California, according to recently published findings.

Life Care Centers takes Gold in Transitions category

Life Care Centers takes Gold in Transitions category

Life Care Centers of America has won the Gold Award in the McKnight's Excellence in Technology Awards in the Transitions category.